BlackRock, Inc. - 31 Mar 2025 SCHEDULE 13G/A Report for Syndax Pharmaceuticals Inc Common Stock (SNDX)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: Syndax Pharmaceuticals Inc Common Stock
Symbol: SNDX
Shares outstanding: 86,462,167 shares
Disclosed Ownership: 6,744,049 shares
Ownership: 7.8%
Form type: SCHEDULE 13G/A
Filing time: 17 Apr 2025, 09:35:29 UTC
Date of event: 31 Mar 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	7.8%	6,744,049	6,651,472	0	Spencer Fleming	Managing Director